The latest closing stock price for GT Biopharma as of November 20, 2024 is 3.19.
An investor who bought $1,000 worth of GT Biopharma stock at the IPO in 2021 would have $-384 today, roughly 0 times their original investment - a -11.41% compound annual growth rate over 4 years.
The all-time high GT Biopharma stock closing price was 18.96 on June 02, 2021.
The GT Biopharma 52-week high stock price is 10.66, which is 234.2% above the current share price.
The GT Biopharma 52-week low stock price is 0.17, which is 94.7% below the current share price.
The average GT Biopharma stock price for the last 52 weeks is 2.62.
An investor who bought $1,000 worth of GT Biopharma stock at the IPO in 2021 would have $-384 today, roughly 0 times their original investment - a -11.41% compound annual growth rate over 4 years.
The all-time high GT Biopharma stock closing price was 18.96 on June 02, 2021.
The GT Biopharma 52-week high stock price is 10.66, which is 234.2% above the current share price.
The GT Biopharma 52-week low stock price is 0.17, which is 94.7% below the current share price.
The average GT Biopharma stock price for the last 52 weeks is 2.62.